Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: Study of the Effects of Mecamylamine and Varenicline in Schizophrenia [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of mecamylamine and varenicline on cognition in schizophrenia; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mecamylamine (mecamylamine)
  • Varenicline (varenicline)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cognition in Schizophrenia | NA | Status: COMPLETED | Results posted: 2017-03-28